Multiplex Taqman Probe Real Time PCR Auto Fast molecular detection qPCR instrument

Product Characteristics:

"Simple microvalve"and"micro channel"core technology Complete the free mixing and separation of the liquid

Realize the integration,integration and simplicity of the detection platform

Product para:

Automatic nucleic acid detection and analysis system:

Fully enclosed detection design,avoid pollution
Disposable detection cardbox design,each sample independent detection,avoid between samples
Fully automatic detection,truly realize the sample into the result
Nucleic acid extraction,nucleic acid detection automation,manual operation less than 1 minute,free hands and reduce manual error
Extremely high detection efficiency,detection time within 1.5 hour
This greatly reduces the time required by traditional PCR laboratory from sample processing to result out put
Provide quantitative detection results of concentration value, more professional and accurate
Support absolute quantification,relative quantification,isothermal amplification, genotyping,endpoint fluorescence analysis and other experimental functions

Product Detail photos:

Back sight of AutoFast qPCR:

Bottom sight of AutoFast qPCR:

Left sight of AutoFast qPCR:

Right sight of AutoFast qPCR:

Bio key Health is a high-tech enterprise with integrating R&D, production and sales&marketing in Guangzhou. Since 2003. Bio Key was founded by the "Thousand Talents Program" entrepreneurial team and the overseas senior automation equipment development engineer team.

The company's core team has been in the field of IVD research and entrepreneurship for more than 10 years, and has mastered a wealth of molecular diagnostic POCT industrial application technology, SmartTRF immune detection technology, RT qPCR nucleic acid detection technology and independent research and development capabilities of instruments.

It has a number of independent core technologies in the fields of automation engineering, micro-precision manufacturing, immunofluorescence, nucleic acid detection and gene sequencing. Since its establishment, the company has applied for more than 60 patents and currently has 17 authorized patents. The company has two R&D centers for diagnostic reagents and instruments and equipment, totaling more than 500 square meters; it has established more than 2,000 square meters of GMP workshops and equipment production plants; it has SmartTRF new immune detection technology, nucleic acid detection technology (POCT) and three scientific services.